Tobramycin
Top View
- Tobramycin Ophthalmic
- Binding of Tobramycin Leads to Conformational Changes in Yeast Trnaasp and Inhibition of Aminoacylation
- Epidemiological and Phylogenetic Analysis Reveals Flavobacteriaceae As Potential Ancestral Source of Tigecycline Resistance Gene Tet(X)
- Sales of Veterinary Antimicrobial Agents in 31 European Countries in 2018
- Annual Report of Antibiotic and Antimycotic Consumption 2019
- 2004 Norm Norm-Vet
- Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella Pneumoniae Pneumonia–Septicemia Model in Rats
- Ophthalmic Ointment Monographs: Tobramycin and Dexamethasone Ophthalmic Ointment
- Antibiotic Recommendations for Sepsis and Septic Shock
- Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics Against Carbapenem–Resistant Acinetobacter Baumannii
- Aminoglycosides Stems from Their High Affinity Binding to The
- TYGACIL (Tigecycline) Is a Tetracycline Derivative (A Glycylcycline) for Intravenous Infusion
- Electronic Supplementary Information (ESI)
- (Tobramycin) Eye Drops TOBREX
- Biochemical Basis of Resistance to Hygromycin B in Streptomyces Hygroscopicus - the Producing Organism
- Biosynthesis of 2-Deoxystreptamine
- Anti-Infective Eye Preparations PHARMACY
- Tobramycin Ophthalmic Solution) 0.3%